Newsletter | June 16, 2025

06.16.25 -- Will Genome Modifications Define Next-Gen AAV Vectors?

SPONSOR

Mobius® iFlex Bioreactors for upstream processes are a scalable portfolio of stirred tank bioreactors that leverage single-use bags with enhanced strength, made with our innovative Ultimus® film. Perfusion applications are supported with ease by integrating a perfusion tower, that uses the Cellicon® Filter Assemblies to retain cells in the bioreactor vessel while removing spent media. Future-proof your process with modular flexibility, and request a demo or technical consultation with our experts today!

FOCUS ON UPSTREAM MANUFACTURING

Will Genome Modifications Define Next-Gen AAV Vectors?

AAV vectors composed of naturally occurring capsids are suboptimal. Gentle genetic alterations hold promise for safer, more efficient therapy.

How To Maximize Cell Line Productivity And Efficiency

Explore some of the key considerations in cell line development, how advances in technology are improving the efficiency and productivity of cell lines, and the future of cell line development.

A Beginner's Guide To Cell Therapy Bioprocessing

Take a deeper look into innovative solutions for researchers facing challenges throughout the development of novel cell and gene therapeutics.

Tackling Allogeneic Immunotherapy's Scale-Up Bottleneck

New bioreactor technology provides an optimal environment for shear-sensitive cells, addressing key scale-up challenges for allogeneic therapies from research to commercial production.

Optimizing The Path To First-In-Human Clinical Trials: Design And De-Risk

Explore the ways to design and de-risk molecules, streamlining the path to GMP manufacturing and clinical trials, and case studies that provide insight into key activities.

Cell Line Development For Multi-Chain Biologics

Examine the application of a platform in creating CHO cell lines for manufacturing multi-chain biologics and the future considerations for 3-chain and 4-chain molecules, including chain ratio balancing.

A Two-Part Strategy To Streamline The Path To FIH

In cell line development, application of targeted integration cell line technology boosts development speed. Then, a proven production platform facilitates seamless scaleup to GMP manufacturing.

Study Viral Infection In Resting Humans CD4+ T Cells With Synthetic sgRNAs

Discover how Synthego's proprietary synthetic sgRNA, combined with Lonza’s 4D-Nucleofector®, enabled highly efficient gene editing in resting human CD4+ T cells.

SPONSOR

Webinar: Scaling up your E. coli pDNA process from parameter screening to pilot scale with advanced single-use bioreactors

Part 1 in an exciting 3-part webinar series to accelerate your pDNA and mRNA process development. Click here to learn more.

UPSTREAM MANUFACTURING SOLUTIONS

Oligosynthesizers For Solid Phase Oligonucleotide Synthesis - Asahi Kasei Bioprocess

IVGE Process And Optimization - Roche CustomBiotech

A Scaled-Down Solution For Simple, Robust Upstream Intensification - Repligen

SPONSOR

Explore the latest biotech equipment and solutions — all online, wherever you are.

Don't miss the next Bio-Expo Live! This interactive, multi-day event is organized by stages of drug development and production, making it easy to find sessions tailored to your company's needs. Browse the full agenda and register for free to join the conversations most relevant to your work.

Connect With Bioprocess Online: